Dundee, Scotland, 18 March 2009: Axis-Shield plc (LSE:ASD, OSE:ASD), the international in-vitro diagnostics (IVD) company, today announces that a new paper has been published confirming the performance of its Afinion Point-of-Care System and the assay for HbA1c, used to monitor efficacy of blood glucose control in diabetes.